COR2ED - Oncology Medical Conversation Video
Pre-analytical phase challenges and biomarker testing in HER2+ metastatic breast cancer
· 23 min · Sesong 6
Episodebeskrivelse
Pre-analytical Phase Challenges and Biomarker Testing in HER2+ Metastatic Breast Cancer
Key clinical takeaways:
Metastatic breast cancer (mBC) is a complex, heterogeneous disease requiring multidisciplinary collaboration. Pathologists are central to this process to ensure accurate interpretation and optimal patient management
Incorporating HER2-low and HER2-ultralow categories in biomarker testing is critical for mBC due to the demonstrated efficacy of HER2-targeted antibody-drug conjugates, such as trastuzumab deruxtecan, in these patient subsets, expanding therapeutic options beyond…
Nettsted: oncology-medical-conversation-video.castos.com
